Intervention

defined green tea catechin extract

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions14

Lead sponsors shown3

Clinical trials

5 shown

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal SputumNCT00573885 · 2008-01-01

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast CancerNCT00516243 · 2007-07-01

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateNCT00459407 · 2007-03-01

Green Tea Extract in Treating Current or Former Smokers With Bronchial DysplasiaNCT00611650 · 2006-10-01

Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryNCT01340599 · 2006-10-01

Common conditions

Lung Cancer2 Stage I Prostate Cancer2 Tobacco Use Disorder2 Adenocarcinoma of the Prostate1 Estrogen Receptor-negative Breast Cancer1 Precancerous Condition1 Progesterone Receptor-negative Breast Cancer1 Stage I Breast Cancer1 Stage II Breast Cancer1 Stage II Prostate Cancer1 Stage IIA Prostate Cancer1 Stage IIB Prostate Cancer1 Stage IIIA Breast Cancer1 Stage IIIB Breast Cancer1

Leading sponsors

British Columbia Cancer Agency2 National Cancer Institute (NCI)2 Case Comprehensive Cancer Center1

Trial status mix

COMPLETED3

TERMINATED2

Phase mix

PHASE23

PHASE12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.